Summary
Discover how decentralized clinical trials are transforming clinical research as Thomas Lethenborg, CEO of Monsenso, shares insights into the opportunities, challenges, and future direction of trials conducted in real-world settings.
Speaker
Thomas Lethenborg is CEO of Monsenso, a digital health company supporting patient-centred care and research through real-world data and remote monitoring solutions.
Atrium Pulse
Is our webinar series made to inspire and connect life science professionals with the experts shaping the industry’s future.
Every two weeks, we pair 15 minutes of sharp insight from a leading voice in the field with 15 minutes of live Q&A - free, online, and open to everyone curious about where life science is heading.
Key words
- Decentralized Clinical Trials (DCT)
- Clinical Research
- Real-World Data (RWD)
- Patient-Centric Research
- Digital Health Innovation
Save information for later
Course leader & lecturers
- Thomas LethenborgLecturerCEO
Monsenso A/S
Watch the video
Is this course for you?
If you work in life science and are curious about the trends, innovations, and perspectives shaping the future of the industry, this webinar is for you.
What you will learn
- Insights into how decentralized trial models can support more patient-centric, scalable, and data-driven clinical research.
What your company will get
- An employee who has broadened their understanding of emerging trends and innovations in clinical trial design.
Course calendar
Day 1
- A 15 minute expert presentation followed by a 15 minute live Q&A
Course information
Literature
Prerequisites
Examination
Course leader
Lecturer
Monsenso A/S
3 Nov 2026
•